介入疗法治疗子宫肌瘤的临床价值

Clinical value of interventional therapy for uterine fibroids

目的探究子宫肌瘤患者应用介入疗法治疗的临床效果。方法选取本院2015年9月～2017年7月收治的52例子宫肌瘤患者,均实施介入疗法治疗,对患者治疗前与介入治疗后的子宫体积、肌瘤体积、月经周期、月经持续时间、月经量、促黄体生成素、雌二醇、促卵泡生成素水平以及并发症发生率进行对比。结果介入治疗后3个月、6个月、9个月的子宫体积与肌瘤体积均小于治疗前(P<0.05);且介入治疗后6个月的子宫体积与肌瘤体积小于介入治疗后3个月(P<0.05);且介入治疗后9个月的子宫体积与肌瘤体积小于介入治疗后6个月(P<0.05);治疗前与治疗后月经周期、月经持续时间与月经量的对比(P<0.05);患者治疗前与治疗后促黄体生成素、雌二醇、促卵泡生成素水平的对比(P>0.05);患者并发症发生率13.46%,经过7天的治疗后,并发症症状彻底消失。结论子宫肌瘤患者应用介入疗法治疗的临床效果显著,可使患者的临床症状显著改善。

Objective To investigate the clinical effect of interventional therapy in patients with uterine leiomyoma. Methods 52 patients with uterine leiomyoma admitted in our hospital from September 2015 to July 2017 were treated with interventional therapy. The uterine volume, myoma volume, menstrual cycle, menstrual duration and menstrual volume were measured before and after interventional therapy. The levels of luteinizing hormone, estradiol, follicle stimulating hormone and the incidence of complications were compared. Results The uterine volume and myoma volume of 3 months, 6 months and 9 months after interventional therapy were smaller than those before treatment (P < 0.05), and the uterine volume of 6 months after interventional therapy was lower than that of pretherapy (P < 0.05). The volume and volume of myoma were smaller than 3 months after interventional therapy (P < 0.05), and the volume of uterus and myoma in 9 months after interventional therapy was smaller than that in 6 months after interventional therapy (P < 0.05). The comparison between menstrual duration and menstrual volume (P < 0.05), luteinizing hormone, estradiol, and follicle stimulating hormone levels before and after treatment (P > 0.05). The incidence o f complications was 13.460.After 7 days of treatment, the complications completely disappeared. Conclusion The clinical effect o f interventional therapy in patients with uterine leiomyoma is remarkable. The clinical symptoms were significantly improved.